Cite
HARVARD Citation
Karthik, C. et al. (2018). Development of piperazine-1-carbothioamide chitosan silver nanoparticles (P1C-Tit*CAgNPs) as a promising anti-inflammatory candidate: a molecular docking validation. MedChemComm. 9 (4), pp. 713-724. [Online].